Meritxell Bellet-Ezquerra
Overview
Explore the profile of Meritxell Bellet-Ezquerra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
97
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Llinas-Bertran A, Bellet-Ezquerra M, Seoane J
Cancer Discov
. 2024 May;
14(5):704-706.
PMID: 38690600
Rosano, Sofyali, Dhiman, and colleagues show that epigenetic-related changes occur in endocrine therapy (ET)-induced dormancy in estrogen receptor positive (ER+) breast cancer, as well as in its reawakening. Targeting these...
2.
Nader-Marta G, Debien V, Eiger D, Tsourti Z, Caparica R, Kassapian M, et al.
Br J Cancer
. 2022 Sep;
127(10):1799-1807.
PMID: 36050448
Background: Patients with small node-negative HER2-positive breast cancer are commonly treated with paclitaxel and 1 year of adjuvant trastuzumab. We performed a sub-analysis of the ALTTO trial to explore the...
3.
Mayer E, Dueck A, Martin M, Rubovszky G, Burstein H, Bellet-Ezquerra M, et al.
Lancet Oncol
. 2021 Jan;
22(2):212-222.
PMID: 33460574
Background: Palbociclib added to endocrine therapy improves progression-free survival in hormone-receptor-positive, HER2-negative, metastatic breast cancer. The PALLAS trial aimed to investigate whether the addition of 2 years of palbociclib to...